Particle.news

India to Dedicate First Indigenous H5N1 Chicken Vaccine

Designed as an inactivated vaccine matched to Clade 2.3.2.1a, it seeks to protect commercial layer and breeder flocks.

Overview

  • Union Agriculture Minister Shivraj Singh Chouhan will dedicate the vaccine to the nation at ICAR’s NIHSAD in Bhopal on Friday, Nov. 20.
  • The shot was developed by the Indian Council of Agricultural Research’s National Institute of High Security Animal Diseases and is targeted specifically at H5N1 Clade 2.3.2.1a viruses.
  • Officials describe the product as an inactivated (killed-virus) vaccine and say trials on layer and breeder chickens produced encouraging safety and effectiveness signals.
  • Reports state a single dose may protect birds for up to six months, but those duration and efficacy claims have not been independently verified and details on regulatory clearance, production scale and cost were not given.
  • The vaccine is aimed at commercial layer and breeder operations to limit culls and economic losses from recurring H5N1 outbreaks since 2006 and to reduce chances of bird-to-human transmission.